This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (202) Citing Articles via Google Scholar Google Scholar Articles by Healey, J. S. Articles by Connolly, S. J. Search for Related Content PubMed PubMed Citation Articles by Healey, J. S. Articles by Connolly, S. J.

Prevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers

A Meta-Analysis

Jeff S. Healey, MD^_*,_*, Adrian Baranchuk, MD^_*, Eugene Crystal, MD, Carlos A. Morillo, MD^_*, Michael Garfinkle, BA, Salim Yusuf, MD, PhD^_* and Stuart J. Connolly, MD^_*

^_* Population Health Research Institute, McMaster University, and Hamilton Health Sciences, Hamilton, Ontario, Canada
University of Toronto, Toronto, Ontario, Canada.

View larger version (31K): [in a new window]   Figure 1 Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs). CI = confidence interval; RR = relative risk.

View larger version (36K): [in a new window]   Figure 2 Prevention of atrial fibrillation in various patient populations. Abbreviations as in Figure 1.